Vertex Pharmaceuticals Inc VRTX:NASDAQ

Last Price$206.61Cboe Real-Time Last Sale as of 9:55AM ET 11/15/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+1.61(0.79%)
Bid (Size)$206.40 (100)
Ask (Size)$206.60 (100)
Day Low / High$205.30 - 206.64
Volume100.9 K

Research Alert: CFRA Raises Opinion On Shares Of Vertex Pharmaceuticals, Inc. To Buy From Hold

2:15PM ET 10/09/2019 MT Newswires
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We are lifting our opinion on shares of VRTX because we have become less concerned about the company's late 2018 and early 2019 CFO departures. We still think that there is some chance that the CFO departures may relate to accounting concerns; however, the positive potential of VRTX's early- to mid-stage stage clinical candidates outweigh the risks, in our opinion. For example, VRTX is researching and developing non-opioid based pain therapy and CRISPR-based gene-editing capabilities -- technologies that hold great promise if successful. We think that VRTX's current valuation mostly captures the value of the company's cystic fibrosis franchise and does not assign much value to the company's early- to mid-stage pipeline. In addition, the company is in a financially strong position from a debt and cash flow perspective, which we view favorably, especially given growing concerns of declining macroeconomic conditions.